12.07.2015 Views

Bernard Taverne, Alice Desclaux, Papa Salif Sow

Bernard Taverne, Alice Desclaux, Papa Salif Sow

Bernard Taverne, Alice Desclaux, Papa Salif Sow

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPITRE II-4L'observance au traitement, tendance à long terme42. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highlyactive antiretroviral therapy assessed by pharmacy claims predictssurvival in HIV-infected South African adults. J Acquir ImmuneDefic Syndr. Sep 2006;43(1):78-84.43. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviraltherapy at primary care sites in Zambia: feasibility and early outcomes.Jama. Aug 16 2006;296(7):782-793.44. Crane JT, Kawuma A, Oyugi JH, et al. The price of adherence:qualitative findings from HIV positive individuals purchasing fixeddosecombination generic HIV antiretroviral therapy in Kampala,Uganda. AIDS Behav. Jul 2006;10(4):437-442.45. Nwauche C, Erhabor O, Ejele O, Akani C. Adherence to antiretroviraltherapy among HIV-infected subjects in a resource - limitedsetting in the Niger Delta of Nigeria. African Journal of HealthSciences. 2006;13:13-17.46. Rosen S, Ketlhapile M, Sanne I, DeSilva MB. Cost to patientsof obtaining treatment for HIV/AIDS in South Africa. S Afr Med J.Jul 2007;97(7):524-529.ird-00718213, version 1 - 16 Jul 201247. Wakabi W. Low ART adherence in Africa. Lancet Infect Dis.Feb 2008;8(2):94.48. Costagliola D, Barberousse C. Comment mesurer l'observance?In: Bessette D, Bungener M, Costagliola D, Flori YA,Matheron S, Morin M, Setbon M, Souteyrand Y, editors.L’observance aux traitements contre le VIH/sida: mesure, déterminants,évolution. Collection sciences sociales et sida. Paris:ANRS, 2002 ;33–42.49. Farmer KC. Methods for measuring and monitoring medicationregimen adherence in clinical trials and clinical practice. Clin Ther.Jun 1999;21(6):1074-1090; discussion 1073.50. Stone VE. Strategies for optimizing adherence to highly activeantiretroviral therapy: lessons from research and clinical practice.Clin Infect Dis. Sep 15 2001;33(6):865-872.51. De Beaudrap P, Etard JF, Ecochard R, et al. Change over timeof mortality predictors after HAART initiation in a Senegalesecohort. Eur J Epidemiol. 2008;23(3):227-234.99

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!